| Date | Title | Description |
| 12.09.2025 | Cascade Bio: $6 Million To Advance Cell-Free Biomanufacturing | Cascade Bio, an industrial biotechnology company based in Denver, has closed $6 million in funding to accelerate the transition from petrochemical processes to enzyme-driven manufacturing. The funding includes a $2.8 million seed round led ... |
| 22.07.2025 | Latent Labs aims to replace trial-and-error drug discovery with push-button design | Today Latent Labs launches Latent-X, a frontier AI model for push button protein design, which outperforms competing models under identical laboratory conditions.
Latent Labs is working to transform the expensive, labour-intensive, and high... |
| 13.02.2025 | Latent Labs: The New Frontier in Programmable Biology | In the world of biotechnology, a new player has emerged, ready to rewrite the rules. Latent Labs, a London-based startup, has burst onto the scene with a staggering $50 million in funding. This infusion of capital is not just a number; it’s... |
| 13.02.2025 | AI pioneer Dr Simon Kohl's Latent Labs emerges from stealth, raising $50M for programmable biology | AI foundation model builder Latent Labs today emerged from stealth with $50 million in total funding to accelerate their progress in programmable biology.
The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein ... |
| 29.11.2024 | Cradle Secures $73M to Revolutionize Planetary Health with AI-Driven Protein Engineering | AI biotech company Cradle has raised $73 million in a Series B funding round led by IVP and backed by Index Ventures and Kindred Capital, bringing its total funding to over $100 million.
Based in Amsterdam, the Netherlands, and Zurich, Swit... |
| 29.10.2024 | Massachusetts: The Beacon of Sustainable Biotech Innovation | Massachusetts is a powerhouse in biotechnology. It’s a state where innovation blooms like spring flowers. The rich soil of education, research, and collaboration nurtures groundbreaking advancements. This article explores how Massachusetts ... |
| 27.10.2024 | The Role of Massachusetts in Promoting Sustainable Biotech Solutions | Share
Tweet
Share
Share
Email
Massachusetts stands at the forefront of biotechnology innovation, particularly in sustainable solutions. With a rich history in education and research, this state has nurtured an ecosystem that fosters groundb... |
| 18.09.2024 | ArkeaBio: Vaccination is ‘the lowest cost and easiest to scale’ livestock methane reduction solution | Multiple strategies are being explored to address methane emissions from belching livestock from cattle breeding programs and feed additives to editing the genes of the microbes in the rumen. But by far the most cost-effective way to tackle... |
| 29.07.2024 | Predicta Biosciences: Pioneering a New Era in Cancer Diagnostics | Predicta Biosciences is making waves in the ocean of cancer diagnostics. With a fresh infusion of $5.2 million in seed funding, this Boston-based precision oncology company is poised to change the landscape of how we detect and treat blood ... |
| 27.07.2024 | Predicta Biosciences Raises $5.2 Million To Develop Novel Diagnostic And Therapeutic Products | Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, announced it had raised an oversubscribed $5.2 million seed round led by The Engine Ventures. And additional participating investors in... |
| 12.12.2022 | High isotropy achieved by novel printable polyimide created by industrial 3D printers manufacturers’ trio | A group of industrial 3D printing firms Zymergen, Hexagon, 3D4Makers, and AON3D have performed an experiment on the new 3D printing polymer, Z2 Polyimide.
The novel, easy-to-3D print formulation of Polyimide offered impressive findings in e... |
| 28.07.2022 | The Week in Agrifoodtech: FreshRealm, Kitchen United score mega-deals in a downturn, Arable raises $40m | Despite the current downturn in tech, FreshRealm landed a mega-deal recently, as did ghost kitchen network Kitchen United. In agtech, Normative bagged funds for its carbon reporting platform and old favorites like donuts and avocados are go... |
| 26.07.2022 | Tech M&A’s surprising acceleration despite a sputtering economy | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Kevin Kelleher here.
Paid Content What you should know about health equity and why From Elevance ... |
| 10.05.2022 | Pow.bio’s continuous fermentation technology might be the key to scaling up food production for a growing population | Fermentation, the process of breaking down sugars using the enzymes of microorganisms, is almost as old as civilization itself. The use of microbial cultures to preserve and improve the nutritional value of foods and produce alcoholic bever... |
| 08.09.2021 | In the hunt for novel antibiotics, will new technology overtake underwater exploration? | LAKE SUPERIOR — Choppy, windswept waves slap at the hull as our boat nears the last known location of the Lucerne, a schooner that sank to the bottom of Lake Superior in 1886. The wreck, just off a narrow sand peninsula jutting from the nor... |
| 04.05.2021 | Zymergen Hires Former Apple Executive and Ford Motor Leader as Chief Manufacturing Officer | |
| 27.04.2021 | High-Stakes: SoftBank Vision Fund | High-Stakes is a unique series that focuses on dissecting the investments of venture capital and private equity firms to gain insights into the portfolio of companies they’ve invested in, industries they focus on, and their investment proce... |
| 23.04.2021 | Zymergen's stock jumps after $500M IPO | Shares of Zymergen rose more than 21% in the company's first day of trading on the Nasdaq, closing at $37.65 apiece. At that price, the synthetic biology company was worth nearly $3.6 billion based on the number of shares outstanding, compa... |
| 22.04.2021 | ‘Biofacturing’ Firm Zymergen Raises $500 Million in Expanded IPO
‘Biofacturing’ Firm Zymergen Raises $500 Million in Expanded IPO | (Bloomberg) -- Zymergen Inc., which uses biological processes to manufacture chemicals, raised $500 million in an upsized initial public offering priced at the top of a marketed range.
The company sold 16.13 million shares Wednesday for $31... |
| 24.02.2021 | Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer | |
| 12.01.2021 | Syngenta Ventures on ChemChina, business model innovation and "agri-fintech" | |
| 12.01.2021 | Agtech CVC: Syngenta Ventures on ChemChina, business model innovation & ‘agri-fintech’ | This interview is part of a series on agrifoodtech corporate VC investment strategies and insights. The series is produced in collaboration with the OnRamp Agriculture Conference, which brings together the agriculture and food industries’ l... |
| 09.09.2020 | Zymergen raised $300 million because synthetic biology is so hot right now | Zymergen, one of the companies that’s developing biomanufacturing technologies that could reshape any number of industries, said it has raised $300 million in financing.
It’s part of a wave of biotech companies that TechCrunch covered in de... |
| 08.09.2020 | Zymergen Takes Aim at $3 Trillion Chemical & Materials Industry With $300 Million in New Funding
USA - English
USA - English
Deutschland - Deutsch
France - Français | |
| 08.09.2020 | Zymergen Raises $300M in Funding | Zymergen, an Emeryville, Calif.-based science and material innovation company, raised $300M in funding.
The investment included initial Series D funding led by Baillie Gifford, joined by Baron Capital Group and one of the world’s largest so... |
| 15.07.2020 | IndieBio’s Arvind Gupta Joins Mayfield, Will Lead New Alliance Using Capitalism And Biology To Do Good In The World | The Genesis Consortium will elevate their work to transform human and planetary health with engineering biology |
| 17.01.2020 | Deep tech VCs on what they view as some of the most impactful young startups right now | During this week’s Democratic debate, there was a lot of talk, unsurprisingly, about ensuring the future of this country’s children and grandchildren. Climate change was of particular interest to billionaire Tom Steyer, who said repeatedly ... |
| 27.09.2019 | How To Spot A Synthetic Biology Unicorn | Biotech is projected to reach $775 billion by 2024, but dozens of companies in the field of ... [+] synthetic biology are creating magical tools to go beyond that. Look here for the next unicorn. Jelena Trmčić for SynBioBeta |
| 20.01.2019 | The AI market is growing, but how quickly is tough to pin down | Holden Page Contributor
Share on Twitter
Holden Page is an editor and journalist at Crunchbase News.
More posts by this contributor
Furniture startups skip the showroom and go straight to your door
If you work in tech, you’ve heard about ar... |
| 11.01.2019 | The AI Market Is Growing, But How Quickly Is Tough To Pin Down | 33 Shares Email Facebook Twitter LinkedIn
If you work in tech, you’ve heard about artificial intelligence: how it’s going to replace us, whether it’s over-hyped or not, and which nations will leverage it to prevent, or instigate, war.
Follo... |
| 14.12.2018 | SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology contract manufacturing platform.
Sponsored by Agilent Technologies
How would you like to win free bench ... |
| 13.12.2018 | Zymergen Raises $400M in Series C Funding | Zymergen, an Emeryville, Calif.-based molecular manufacturing technology company, raised over $400m in Series C funding.
The round was led by returning investor SoftBank Vision Fund, with participation from new investors Goldman Sachs and H... |
| 13.12.2018 | Zymergen lands $400 million more, led by SoftBank Vision Fund, for its genetically altered microbes | Zymergen, a five-year-old company that manufacturers molecules for a wide array of uses and industries, has closed on $400 million in Series C funding led by one of its earlier investors, the SoftBank Vision Fund.
Even in a world where trip... |
| 13.12.2018 | SoftBank Vision Fund leads $400m round for synthetic bio startup Zymergen | Premium
Joshua Hoffman has done plenty of experimentation at Zymergen Inc., the robot-powered microbe factory he founded and leads.
Continue reading this story with a subscription to DealStreetAsia.
Subscribe
Already a subscriber? Log in
Co... |
| 13.12.2018 | Zymergen Lands $400M Series C |
EMERYVILLE, CA, Zymergen, the world's first molecular manufacturing technology company, announced today it has raised over $400 million in Series C funding.
>> Click here for more funding data on Zymergen
>> To export Zymerg... |
| 13.12.2018 | Term Sheet — Thursday, December 13 | THE 2018 STATE OF STARTUPS
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
Here are some of the most interesting takeaways from the report:
What is investors’ strongest bias?
Founders see... |
| 13.12.2018 | Zymergen Raises $400m Series C in Largest Ever Upstream AgriFood Tech Deal in US | *Editor’s Note: This story has been updated to include comment from Matt Ocko, co-managing director and co-founder of Data Collective VC.
Zymergen, a synthetic biology startup engineering microbes for a range of tasks, has closed a $400 mil... |
| 30.10.2018 | True Ventures has two new funds totaling $635 million to plug into a wide range of startups | True Ventures never seems to be short on exits. Most recently, the 13-year-old venture firm saw early checks to Ring, Blue Bottle Coffee, Duo Security and Evident.io pay off via exits to Amazon, Nestle, Cisco and Palo Alto Networks, respect... |
| 26.04.2018 | Monsanto’s Venture Arm Could Be Winding Down, Sources Suggest, As Company Looks for New Talent | *Updated April 27, 2018, 15:35 to add more context around future of MGV.*
Monsanto Growth Ventures (MGV), the venture arm of Monsanto, has lost all of its dedicated staff after former managing director John Hamer, former investment director... |
| 04.01.2018 | 30 Food Technologies to Support Your Sustainable New Year’s Resolutions | When it comes to technology in the first week of January, you might be thinking wearable fitness trackers and meal replacements. But there is a whole host of startups with technology that can also help with resolutions skewed toward agricul... |
| 14.12.2017 | Ginkgo Bioworks Raises $275m Series D for Robotic Microbe Factory Expansion | **Update: Added comments from Ginkgo Bioworks CEO Jason Kelly**
Ginkgo Bioworks, a Boston startup genetically engineering microbes for partner companies in the flavor, fragrance, agriculture, and food industries, has raised $275 million in ... |
| 04.11.2017 | Bay-Area biotech startup Zymergen opens Seattle office, signaling big growth plans in the city | (Screen shot via Zymergen.com)
Seattle is the second home to yet another startup based in the San Francisco area.
That company is Zymergen, a heavily-funded biological engineering startup, which has announced the opening of a new Seattle of... |
| 11.06.2017 | 50 компаний в области искусственного интеллекта, за которыми стоит следить Статьи редакции | Подборка от сайта KD Nuggets.
12 12 комментариев
42 981 просмотров
Продажи и CRM
InsideSales.com — платформа для роста продаж, использующая предиктивные самообучающиеся алгоритмы. Компания привлекла более $251 млн инвестиций.
Persado — сис... |
| 07.12.2016 | After meeting with Trump, Sprint chairman pledges to invest $50B in U.S., raising questions about a T-Mobile merger | Masayoshi Son and Donald Trump. (Wikimedia Photos)
After Japanese billionaire Masayoshi Son’s company SoftBank acquired a majority stake in Sprint, he sought to merge the Kansas telecom provider with Bellevue, Wash.-based T-Mobile. U.S. reg... |
| 04.11.2016 | Heavily-funded Bay Area startup opening office in Seattle to fuel biological engineering | Zymergen, a biological engineering startup based in the San Francisco area, is building out an engineering center in Seattle, GeekWire has learned.
A Zymergen spokesperson confirmed that the company’s Seattle office, located in the World Tr... |
| 03.11.2016 | The top 15 healthcare deals of 2016 | There has been $13.1 billion invested across 1,287 deals so far this year
Even as venture funding has slowed down this year, healthcare has remained one of the top spaces for companies to raise money.
In the first quarter of this year, even... |
| 13.10.2016 | Agtech Funding Sheet: AnelloTech Raises $1.5m, ZymoChem Raises Seed Round, more | ZymoChem, a company that develops microbes and bioprocesses for eco-friendly chemicals from renewable sources like sugar, closed a $350,000 seed round. Early-stage food, science, biomed, and clean energy investor Breakout Labs was the sole ... |
| 13.10.2016 | Microbe Engineering Startup Zymergen Raises $130m Series B | Zymergen, a startup engineering microbes for use across a range of industries including agriculture, has raised $130 million in Series B funding. This is one of agtech’s largest fundraising deals to-date.
It’s also $30 million more than com... |
| 11.10.2016 | Zymergen Raises $130M in Series B Funding | Zymergen, an Emeryville, CA-based technology company focused industrial biology, raised $130m in Series B funding.
The round was led by SoftBank Group (TOKYO: 9984) with participation from Data Collective (DCVC), as well as return investors... |
| 11.10.2016 | Two Sigma Ventures Joins $130M Series B for Zymergen | EMERYVILLE, Calif.--(BUSINESS WIRE)--Zymergen, a technology company unlocking the power of biology, announced today that it has raised 130 million USD in Series B funding led by SoftBank Group (TOKYO: 9984). The round also includes prior le... |
| 11.10.2016 | Zymergen raises $130 mn to scale robot powered microbe factory | Zymergen charges a subscription fee and takes a share of the improved margins over a certain time period—the goal being to cover costs and get a slice of their customers’ upside. Zymergen raises $130 mn to scale robot powered microbe factor... |
| 11.10.2016 | Zymergen Lands $130M Series B Round |
EMERYVILLE, CA, Zymergen, a technology company unlocking the power of biology, announced today that it has raised $130 million in Series B funding led by SoftBank Group (TOKYO: 9984).
>> Click here for more funding data on Zymergen... |
| 10.10.2016 | Biotech startup Zymergen nabs $130 million from Softbank | Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank.
For those unfamiliar, the company makes crazy new materials out of genetically alter... |
| 08.10.2016 | A startup founder’s playbook for transforming big industry | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Agile development, rapid learning, granular instr... |
| 08.10.2016 | A startup founder’s playbook for transforming big industry | Agile development, rapid learning, granular instrumentation, a large-scale compute and data infrastructure, cutting-edge machine learning — these are the ingredients that give innovative companies their edge.
But to date, this mindset and a... |
| 27.04.2016 | Cloud Biology in Agriculture: Taking Big Data to a New Level | Editor’s Note: Tomorrow at the Global AgInvesting Forum in New York, the first panel discussing Cloud Biology in agriculture will convene involving Matthew Crisp, CEO of Benson Hill Biosystems, Ignacio Martinez, partner at Flagship Ventures... |
| 07.09.2015 | The Next Food Frontier: How AgTech Can Save The World | Dror Berman Contributor
Dror Berman is a founding managing partner at Innovation Endeavors.
Samantha Wai Contributor
Samantha Wai is on the Innovation Labs Team at Innovation Endeavors.
As investors, our job is to find the visionaries that ... |
| 20.06.2015 | Funding roundup - week ending 6/20/15 | Doctor On Demand, Softbank, Namely, Mezaaj, Are You A Human, Framebridge, Spacious, MentAd, GoFundMe
Seed stage
Fashion startup Mezaaj raised an undisclosed amount of seed capital from private investor Arshad Latif.
JiffStore, which offers ... |
| 18.06.2015 | Zymergen Seals $42M Series A to Continue Mass Production of Microbes Using Robotics | Microbial DNA maker Zymergen recently announced a $42M Series A led by Data Collective, with a group of investors participating, including AME Cloud Ventures, Draper Fisher Jurveston, HVF, Innovation Endeavors, Obvious Ventures, True Ventur... |
| 16.06.2015 | Zymergen Raises $44M in Series A Funding | Zymergen, a Emeryville, CA-based company which uses microbes to manufacture high-value chemicals and new materials, raised $44m in Series A funding.
The round was led by Data Collective with participation from AME Cloud Ventures (Jerry Yang... |
| 16.06.2015 | Daily funding roundup - June 16, 2015 | KPCB closed $4M; Zymergen raised $44M; BelezaNaWeb nabbed $30M
Kleiner Perkins Caufield & Byers launched a new seed fund, dubbed KPCB Edge, in an effort to regain its status as a go-to venture capital firm for young entrepreneurs workin... |
| 16.06.2015 | Robots And Microbes: Zymergen Raises $44 Million From Big VCs | - |
| 16.06.2015 | With $44 Million In Funding, Biotech Startup Zymergen Is Buying Up Robots To Mass Produce Materials From Microbes | The mostly under-the-radar biotech startup Zymergen has gone about making microbial DNA manipulating robots for the last couple of years. It has now raised a total of $44 million to use these microbes to manufacture chemicals and new materi... |
| 16.06.2015 | Zymergen Grabs $44M For “Designer” Microbes Tested by Robots | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Zymergen, an Emeryville, CA-based biotechnology startup, announced $44 million of venture funding this morning for its effort to build better “designer” microbes to make chemi... |
| 16.06.2015 | Zymergen Receives $44M |
EMERYVILLE, CA, Zymergen, which uses robots, big data, and novel software algorithms to unlock the potential of biology to engineer materials of the future, today announced $44 million in funding.
>> Click here for more funding dat... |
| - | The AI-Powered Consumer Startup Revolution is Coming | As artificial intelligence and data science have begun to transform enterprise software, one area where we are excited to see more innovation is in AI-first consumer software startups. Over the past five years, we have seen a proliferation ... |
| - | The Path to Precision Medicine | We believe data-driven companies can create the most powerful solutions to our world’s biggest problems. We have been increasingly excited about the intersection of data science and healthcare / biology and have already made several investm... |
| - | Harnessing the Power of Biology | As early stage investors, we at True have learned to listen closely to the edges of our networks so we can best spot the formation of new industries and identify early market leaders. We also strongly believe in the power of a healthy disre... |
| - | Opportunities at the Intersection of Biology, Software, and Automation | Over the past two decades, we’ve seen hundreds of billions of dollars of market capitalization created by new software and infrastructure companies built at the intersection of mobile, data, and cloud computing.
Now, we’re in the middle of... |
| - | Founder-Focused Investing in Human Health and Biology | Recently, there have been a number of thoughtful blog posts on different models for funding emerging opportunities in human health and biology.
Biotech Researchers Venture Into the Wild to Start Their Own Businesses by Jorge Conde
The $10... |
| - | Meet the 2018 True Entrepreneur Corps Fellows | In 2009, True created a fellowship program to help connect ambitious college students with summer internships at startups. In addition to providing our companies with access to capable assistance, we wanted to help students, who might other... |
